NATRIURETIC PEPTIDES FOR DIAGNOSING CARDIAC COMPLICATIONS DUE TO CORONARY CATHETERIZATION

• 1. 用于治疗视网膜病症和疾病的ANP(心钠素)、BNP(脑钠素)以及CNP(C型利钠肽)相关肽及其衍生物的方法和用途 [P] . 中国专利： CN104039341A . 2014-09-10
• 2. BNP型肽和ANP型肽用于评定由于容量超负荷的结果患上心血管并发症的风险的用途 [P] . 中国专利： CN101107527A . 2008-01-16
• 3. Natriuretic peptides for diagnosing cardiac complications due to coronary catheterization [P] . 美国专利： US8008083B2 . 2011-08-30

  机译： 利钠肽用于诊断冠状动脉导管插入术引起的心脏并发症

• 4. NATRIURETIC PEPTIDES FOR DIAGNOSING CARDIAC COMPLICATIONS DUE TO CORONARY CATHETERIZATION [P] . 欧洲知识产权局专利： EP2064555A1 . 2009-06-03

  机译： 用于冠状动脉介入治疗的心血管并发症的利钠肽

• 5. NATRIURETIC PEPTIDES FOR DIAGNOSING CARDIAC COMPLICATIONS DUE TO CORONARY CATHETERIZATION [P] . 世界知识产权组织专利： WO2008034750A1 . 2008-03-27

  机译： 用于冠状动脉介入治疗的心血管并发症的利钠肽

• 1. N-terminal pro-brain natriuretic peptide but not high-sensitivity C-reactive protein is related to severity of coronary artery stenosis in patients with acute coronary syndrome [J] . Shi-Jun Li, Zhi-Jun Sun, Dan-Dan Li, 老年心脏病学杂志（英文版） . 2010,第002期
• 2. Effect of milrinone on the cardiac function and N-terminal pro-brain natriuretic peptide levels in patients with senile refractory heart failure [J] . Jiao-Na Wei, Rui-Hai Yang, Yong-Jin Wang, 海南医科大学学报（英文版） . 2017,第012期
• 3. Effect of recombinant human brain natriuretic peptide on serum inflammatory factors, neuroendocrine hormones and cardiac function in patients with acute myocardial infarction complicated with heart failure [J] . Shan-Shan Li, Yi-Gang Zhang, Qiu-Mei Cao 海南医科大学学报（英文版） . 2017,第013期
• 4. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Use of Cardiac Troponin and B-Type Natriuretic Peptide or N-Terminal proB-Type Natriuretic Peptide for Etiologies Other than Acute Coronary Syndromes and Heart Failure [J] . Alan B. Storrow, Alan H.B. Wu, Allan S. Jaffe, Clinical Chemistry: Journal of the American Association for Clinical Chemists . 2007,第12期
• 5. Head-to-head comparison of N-terminal pro-brain natriuretic peptide, brain natriuretic peptide and N-terminal pro-atrial natriuretic peptide in diagnosing left ventricular dysfunction. [J] . Hammerer-Lercher A, Neubauer E, Muller S, Clinica chimica acta: International journal of clinical chemistry and applied molecular biology . 2001,第2期
• 6. Use of a highly sensitive assay for cardiac troponin T and N-terminal pro-brain natriuretic peptide to diagnose acute rejection in pediatric cardiac transplant recipients [J] . DyerA.K., BarnesA.P., FixlerD.E., The American heart journal . 2012,第4期
• 7. CARDIAC BIOMARKERS TROPONIN I AND N-TERMINAL PRO-B-TYPE NATRIURETIC PEPTIDE IN CANINE CHRONIC KIDNEY DISEASE PATIENTS [C] . Lena Pelander, Jens Haggstrom, Ingrid Ljungvall Conference of the American^College^of^Veterinary^Internal^Medicine . 2016
• 8. Atrial natriuretic peptide receptor subtype determination and biological actions of atrial natriuretic peptide in bovine cardiac muscle and hypertensive rat liver [D] . McCartney, Shirley. 1992
• 9. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system atrial natriuretic peptide and brain natriuretic peptide. [O] . M Mukoyama, K Nakao, K Hosoda, 1991
• 10. MODERATED EPOSTERS1385Longitudinal strain assessment in dilated cardiomyopathy patients using a novel accelerated DENSE sequence1407Simultaneous T1 and T2 cardiac quantification with CABIRIA: initial clinical experience1423Head-to-head comparison of acceleration algorithms in 4-dimensional flow CMR1502Left ventricular function and size evaluated by hybrid cardiac positron emission tomography-magnetic resonance: Intraindividual comparison of left ventricular ejection fraction and ventricular volumes derived by two modalities1510Left Atrium assessed by Cardiovascular Magnetic Resonance at 1.5 and 3 Tesla – age and gender effects1514Comparison of Free Breathing Cardiac MRI Radial technique to the Standard Multi breath-hold cine SSFP CMR technique for the assessment of LV Volumes and Function1536Self-navigated free-breathing isotropic 3D whole heart phase sensitive inversion recovery magnetic resonance without navigator for detection of myocardial infarction1547Assessment of Right Ventricular Strain Using Myocardial Deformation Recovery Semi Automated Technique: Initial Experience and Normal Values1586Tissue tracking myocardial deformation analysis and prediction of left ventricular remodeling in acute myocardial infarction1589Investigating strategies for optimal 31P MRS clinical cardiac at 3T: Initial Results1620Quantitative Criteria for the Diagnosis of the Congenital Absence of Pericardium by Cardiac Magnetic Resonance1632Widespread tissue injury during acute myocardial infarction: evidence from advanced CMR relaxometry1322Computed tomography coronary angiography verSus sTRess cArdiac magneTic rEsonance for the manaGement of sYmptomatic revascularized patients: a cost effectiveness study (STRATEGY study)1339Comparison of low- versus high-dose of gadobutrol for late gadolinium enhancement imaging at 1.5 Tesla: a clinical feasibility study1347Multi-parametric Cardiac Magnetic Resonance for Prediction of Cardiac Complications in Thalassemia Intermedia: a Prospective Multicenter Study1461Prognostic value of Cardiovascular Magnetic Resonance derived indexes of myocardial fibrosis in heart transplant recipients1523The role of CMR in the acute phase of hospitalization: changing paradigms1542Preoperative CMR-based score predict ventricular response after surgical left ventricular reconstruction in ischemic heart failure patients1555Excellent response rate to cardiac resynchronization therapy guided with magnetic resonance imaging1626The ECG as a predictor of arrhythmogenic substrate on Cardiac Magnetic Resonance Imaging in patients undergoing ablation for premature ventricular contractions1649Comparison of T1-mapping at 3.0T CMR and angiographic APPROACH score for area at risk assessment in ST-segment elevation myocardial infarction1340Pathological correlates of left bundle branch disease in patients with non-ischemic cardiomyopathy: a cardiovascular magnetic resonance study1342Myocardial remodelling and fibrosis in nonischaemic dilated cardiomyopathy: insights from cardiovascular magnetic resonance1411The association between fibrosis and contractile dysfunction in hypertrophic cardiomyopathy assessed by cardiovascular magnetic resonance1622Persistent myocardial inflammation due to intramyocardial haemorrhage in reperfused STEMI as a precursor to adverse LV remodelling - insights from multi-parametric mapping1566Semiquantitative analysis of low and high b value DWI for detecting myocardial edema in acute myocarditis1567Value of Cardiac MRI In Detecting Coronary Artery Disease In Newly Diagnosed Systolic Dysfunction1570Usefulness of cardiac magnetic resonance in tuberous sclerosis complex1578Papillary muscles offer further insight into hypertrophied hearts: a cardiovascular magnetic resonance study1627Diagnostic and clinical implications of CMR timing (early versus late) in patients with troponin positive acute coronary syndromes and unobstructed coronary arteries: Table 1. [O] . Upasana Tayal, Alexandros Kallifatidis, P. Garg, 2016

• 1. N-terminal pro-brain natriuretic peptide but not high-sensitivity C-reactive protein is related to severity of coronary artery stenosis in patients with acute coronary syndrome [J] . Shi-Jun Li ,Zhi-Jun Sun ,Dan-Dan Li . 老年心脏病学杂志 . 2010,第002期
• 2. Relationship between Perioperative N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) and Complications in Thoracic Surgery [J] . Kantaro Hara ,Takuma Tsukioka ,Nobuhiro Izumi . 胸外科期刊（英文） . 2018,第2期
• 3. N末端B型利钠肽对直接PCI治疗的ST段抬高型急性心肌梗死心血管事件的预测价值 [C] . 李春兰 ,陈哲林 ,方填源 . 第四届岭南内科大会 . 2016
• 4. 血浆B型氨基端利钠肽原与中段心房利钠肽在心力衰竭中的诊断与预后价值 [A] . 刘文卉 . 2020